رجوع
48
27
مُدرج أيضًا باسم
FLMNY
OTC
نطاق اليوم
KWD 52.85
KWD 52.90
نطاق 52 أسبوعًا
KWD 42.54
KWD 64.00
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 57.63
/
KWD 60.50
الإغلاق السابق
KWD 52.85
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 29.2 | 0.3 |
| P/B | 4.9 | 2.9 |
| ROE % | 18.0 | 3.7 |
| Net Margin % | 6.7 | 3.8 |
| Rev Growth 5Y % | 12.2 | 10.0 |
| D/E | 1.0 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 3.501
KWD 3.414 – KWD 3.575
|
2.9 B | 6 |
| FY2028 |
KWD 3.340
KWD 3.257 – KWD 3.411
|
2.9 B | 7 |
| FY2027 |
KWD 3.002
KWD 2.927 – KWD 3.066
|
2.7 B | 6 |
النقاط الرئيسية
Revenue grew 12.19% annually over 5 years — strong growth
Earnings grew 21.90% over the past year
ROE of 17.99% — decent returns on equity
Generating 327.41M in free cash flow
Cash machine — converts 215.25% of earnings into free cash flow
Capital efficient — spends only 3.65% of revenue on capex
النمو
Revenue Growth (5Y)
12.19%
Revenue (1Y)14.98%
Earnings (1Y)21.90%
FCF Growth (3Y)33.87%
الجودة
Return on Equity
17.99%
ROIC14.45%
Net Margin6.72%
Op. Margin15.09%
الأمان
Debt / Equity
0.97
Current Ratio0.64
Interest Coverage8.16
التقييم
P/E Ratio
29.18
P/B Ratio4.94
EV/EBITDA15.27
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.98% | Revenue Growth (3Y) | 13.44% |
| Earnings Growth (1Y) | 21.90% | Earnings Growth (3Y) | 21.14% |
| Revenue Growth (5Y) | 12.19% | Earnings Growth (5Y) | 6.92% |
| Profitability | |||
| Revenue (TTM) | 2.26B | Net Income (TTM) | 152.11M |
| ROE | 17.99% | ROA | 6.42% |
| Gross Margin | 80.02% | Operating Margin | 15.09% |
| Net Margin | 6.72% | Free Cash Flow (TTM) | 327.41M |
| ROIC | 14.45% | FCF Growth (3Y) | 33.87% |
| Safety | |||
| Debt / Equity | 0.97 | Current Ratio | 0.64 |
| Interest Coverage | 8.16 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 29.18 | P/B Ratio | 4.94 |
| P/S Ratio | 1.96 | PEG Ratio | 1.06 |
| EV/EBITDA | 15.27 | Dividend Yield | 0.02% |
| Market Cap | 4.44B | Enterprise Value | 5.22B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2.26B | 1.97B | 1.76B | 1.68B | 1.43B |
| Net Income | 152.11M | 124.79M | 103.66M | 136.86M | 116.41M |
| EPS (Diluted) | 1.81 | 1.49 | 1.23 | 1.63 | 1.39 |
| Gross Profit | 1.81B | 1.57B | 1.38B | 1.34B | 1.15B |
| Operating Income | 341.68M | 648.84M | 575.63M | 583.61M | 179.23M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2.37B | 2.02B | 1.77B | 1.74B | 1.67B |
| Total Liabilities | 1.46B | 1.06B | 913.48M | 863.09M | 832.86M |
| Shareholders' Equity | 899.13M | 792.03M | 804.22M | 819.83M | 779.20M |
| Total Debt | 873.85M | 592.15M | 505.66M | 458.26M | 425.72M |
| Cash & Equivalents | 94.29M | 58.93M | 51.25M | 174.89M | 103.72M |
| Current Assets | 545.62M | 510.40M | 489.95M | 538.32M | 518.18M |
| Current Liabilities | 846.71M | 529.51M | 391.79M | 366.29M | 356.30M |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#439 of 1052
Custom
Balanced Risk
#142 of 151
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Balanced Risk
Mar 24, 2026